Nigral volume is examined in a cohort consisting of controls, hyposmic participants with dopamine transporter deficits, RBD, de novo PD (early PD, levodopa naïve at study enrollment), and moderate PD from the Parkinson’s Progression Markers Initiative (PPMI). The gene discussed is SLC6A3; the disease is Parkinson disease.